PSA and Prostate Drugs: Renal Angiomyolipoma Review | Part 2 | 泌尿 | OET Music

Dr Allison Lu · Pip & Barnaby · Medical English

本頁提供本曲完整英文歌詞與影片搭配的繁中醫學提示。歌詞保留原演唱文字；遇到過度簡化或舊門檻，請搭配下方提示與原始資料閱讀。這是概念學習材料，不替代個別醫療評估。

Lyrics · 完整歌詞

All alpha-blockers relax prostatic smooth muscle through alpha-1A receptors within days,
whatever the gland size.
Is the PSA raised with pus cells in the urine?
Treat the infection first and repeat the test before any biopsy.
On imaging, fat density inside a renal mass means angiomyolipoma,
benign until it grows beyond 4 cm.
Luminal narrowing by a gland above 40 mL responds to a 5-alpha-reductase inhibitor,
which halves the PSA within six months.

All alpha-blockers relax prostatic smooth muscle through alpha-1A receptors within days,
whatever the gland size.
Is the PSA raised with pus cells in the urine?
Treat the infection first and repeat the test before any biopsy.
On imaging, fat density inside a renal mass means angiomyolipoma,
benign until it grows beyond 4 cm.
Luminal narrowing by a gland above 40 mL responds to a 5-alpha-reductase inhibitor,
which halves the PSA within six months.

Medical Notes · 醫學學習提示

  1. α阻斷劑鬆弛平滑肌；受體選擇性依藥而異
  2. 數天可開始改善症狀；效果不只由腺體大小決定
  3. 膿尿需評估感染；感染與攝護腺癌可能並存
  4. 確認感染才治療；勿只因無症狀 PSA 高就用抗生素
  5. 正常腎臟示意；腫塊含明顯脂肪常提示血管肌脂肪瘤
  6. 更正：超過 4 公分不等於惡性；治療看出血與其他風險
  7. 腺體較大較能受益；40 mL 並非所有藥物的絕對界線
  8. PSA 約於 6–12 月降一半；依療程與新基準判讀
  9. α1A 是重要受體；藥物選擇性與副作用仍有差異
  10. α阻斷劑可較快緩解症狀；不會明顯縮小腺體
  11. 膿尿不能排除癌症；PSA 不是癌症專一指標
  12. 感染治療後再評估；切片決策結合 MRI、PSA 與風險
  13. 正常腎臟示意；少脂型腫瘤需進一步鑑別
  14. 更正：4 公分不是良惡性分界，也不是唯一治療門檻
  15. 5α還原酶抑制劑適用較大腺體；效果需數月
  16. 用藥後 PSA 需調整判讀；持續上升仍應追查

References